The effect of methotrexate on the bioavailability of oral 6-mercaptopurine

Clinical Pharmacology and Therapeutics

Volumn 41, Issue 4, 1987, Pages 384-387

  Balis, Frank M ^a   Holcenberg, John S ^a   Zimm, Solomon ^a   Tubergen, David ^a   Collins, Jerry M ^a   Murphy, Robert F ^a   Gilchrist, Gerald S ^a   Hammond, Denman ^a   Poplack, David G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE; XANTHINE OXIDASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADVERSE DRUG REACTION; BIOAVAILABILITY; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INTERACTION; DRUG THERAPY; HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; THERAPY;

6-MERCAPTOPURINE; ADMINISTRATION, ORAL; ADOLESCENT; BIOLOGICAL AVAILABILITY; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; FEMALE; HUMANS; KINETICS; LEUKEMIA, LYMPHOCYTIC; MALE; METHOTREXATE;

EID: 0023148505     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.1987.45     Document Type: Article

References (6)